Colleen McCabe

Oct 17, 2024 | pharmacytimes.com | Hunter Sowell |Colleen McCabe |Manuel Cortez |Rachel Gilmore |Elizabeth Davis |Vicki L Keedy

PublicationArticlePeer ReviewedOctober 17, 2024Pharmacy Practice in Focus: OncologyOctober 2024Author(s):This retrospective cohort study provides preliminary evidence for safe removal of mesna from VAdriaC cycles, as the incidence of hemorrhagic cystitis did not increase in patients with Ewing sarcoma who received cyclophosphamide without prophylactic mesna.